Literature DB >> 1675112

P-glycoprotein content and mediation of vincristine efflux: correlation with the level of differentiation in luminal epithelium of mouse small intestine.

M B Meyers1, K W Scotto, F M Sirotnak.   

Abstract

Luminal epithelium from mouse small intestine was fractionated into four distinct components ranging from the most differentiated (absorptive epithelial cells, fraction I) to the least differentiated (proliferative crypt cells, fraction IV). Immunoblot analysis of these fractions with monoclonal antibodies to P-glycoprotein, C219, and HYB-241, indicated that the amount of P-glycoprotein increased in cells as they progressed in level of differentiation from crypt to the villar surface of the lumen of the small intestine. P-glycoprotein in these normal intestinal cells functioned as a transporter of vincristine, one of a group of cancer chemotherapeutic agents to which cells can develop multidrug resistance. Transport ability was shown by efflux studies with vincristine as substrate. Efflux increased with differentiation and correlated with the increase in the amount of P-glycoprotein. Fraction I cells effluxed vincristine about seven times more rapidly than fraction IV cells. Efflux of vincristine was almost entirely inhibited from fraction I cells after treatment with antibody HYB-241, which recognizes an external epitope of P-glycoprotein. This finding would appear to demonstrate that P-glycoprotein was directly responsible for at least the majority of efflux of vincristine in these cells. The observed Mr of P-glycoprotein in fraction I cells was 140,000 when cells were solubilized with sodium dodecyl sulfate at room temperature before electrophoresis and immunoblot analysis. When solubilized fraction I protein was heated with 2-mercaptoethanol before electrophoresis, P-glycoprotein was seen by immunochemical procedures as an Mr 50,000-55,000 protein. No Mr 170,000 or 180,000 forms of P-glycoprotein (forms that are found in multidrug-resistant cell lines and are stable to heat or sulhydryl agents) were detected in any fraction of these epithelial cells under the conditions used. Functional P-glycoprotein was, therefore, associated with differentiation of luminal epithelium in small intestine, and the P-glycoprotein produced by these cells may be a type not previously described.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675112     DOI: 10.3727/095535491820873335

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  10 in total

Review 1.  Determinants of passive drug entry into the central nervous system.

Authors:  M D Habgood; D J Begley; N J Abbott
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors:  H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

3.  The importance of villous physiology and morphology in mechanistic physiologically-based pharmacokinetic models.

Authors:  Emile P Chen; Guoying Tai; Harma Ellens
Journal:  Pharm Res       Date:  2013-08-30       Impact factor: 4.200

Review 4.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

5.  Effect of natural flavonoids to reverse P-glycoprotein-related multidrug resistance in breast cancer cell cultures.

Authors:  Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Am J Cancer Res       Date:  2022-06-15       Impact factor: 5.942

6.  Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers.

Authors:  J Hunter; B H Hirst; N L Simmons
Journal:  Pharm Res       Date:  1993-05       Impact factor: 4.200

7.  Functional expression of the P-glycoprotein mdr in primary cultures of bovine cerebral capillary endothelial cells.

Authors:  D Lechardeur; D Scherman
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

8.  Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins.

Authors:  Daniela Heilos; Clemens Röhrl; Christine Pirker; Bernhard Englinger; Dina Baier; Thomas Mohr; Michaela Schwaiger; Shahid Muhammad Iqbal; Sushilla van Schoonhoven; Kristaps Klavins; Tanja Eberhart; Ursula Windberger; Judith Taibon; Sonja Sturm; Hermann Stuppner; Gunda Koellensperger; Rita Dornetshuber-Fleiss; Walter Jäger; Rosa Lemmens-Gruber; Walter Berger
Journal:  Oncotarget       Date:  2018-05-22

Review 9.  Differential Impact of Flavonoids on Redox Modulation, Bioenergetics, and Cell Signaling in Normal and Tumor Cells: A Comprehensive Review.

Authors:  Asimina Kerimi; Gary Williamson
Journal:  Antioxid Redox Signal       Date:  2017-09-28       Impact factor: 8.401

10.  The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression.

Authors:  A E Trezise; P R Romano; D R Gill; S C Hyde; F V Sepúlveda; M Buchwald; C F Higgins
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.